倍他乐克治疗100例老年冠心病房颤临床分析x

Clinical analyses on the atrial fibrillation in 100 senile patients with coronary heart diseases treated with betaloc

本文报道了应用倍他乐克（或加用洋地黄）治疗老年冠心病房颤１００例的观察组与１００例仅单用洋地黄制剂的对照组进行比较，发现观察组与对照组入院时心率、血压及出院时血压无显著性差异，但出院时心率，２组则有显著性差异（Ｐ＜０．０５），说明使用倍他乐克能有效控制心室率，且对血压无明显影响，也无１例发生毒性反应，而对照组的毒性反应为８％。

Coronary heart diseases is common to old people,and atrial fibrillation is a very frequent clinical manifestation, usually followed by heart failure in varying degrees. UP to now,the treatment for CHD atrial fibrillation in the old people is still to control ventricle rate, but this means is not satisfactory. If digitalis is long period used for a,it can probably cause toxicity reaction. There were 100 cases in this article which showed that the result of betaloc(or adding some digitalis)was better than that of digitalis only,and could avoid the toxicity reaction of digitalis. (100 cases of clinical analysis contrast group were enclosed herewith )